Simplify Logo

Full-Time

Associate Director / Director

Process Development

Confirmed live in the last 24 hours

Vor Bio

Vor Bio

51-200 employees

Develops targeted therapies for blood cancers

Biotechnology
Healthcare

Senior, Expert

Cambridge, MA, USA

Generous transportation stipend offered for commuting.

Category
Genomics
Biology Lab & Research
Biology & Biotech
Requirements
  • PhD in the pertinent life sciences or engineering, with 10+ years relevant experience
  • Excellent cross-functional communication skills
  • Expertise (5-7+ years) leading process development of HSC and/or CAR-T products
  • Process development experience in late-stage program is highly desired
  • Understanding of cGMPs and demonstrated experience leading groups with substantial contributions to regulatory filings
  • Understanding of manufacturing processes for genome editing reagents including Cas9, gRNA, lentiviral vectors
  • Demonstrated track record of consistently meeting deadlines in a dynamic, fast-paced environment
  • Experience in process characterization and validation is a plus
Responsibilities
  • Oversee all aspects of Process Design for HSCs and CAR-T: optimize cell therapy manufacturing process, execute process characterization, author process control strategy, and support process validation
  • As necessary, provide support for the development, characterization, comparability, and validation of critical starting material manufacturing processes, e.g., Cas9, gRNA, and lentiviral vector production
  • Establish strong collaborative relationships and represent Process Development function across the organization and with external partners
  • Author and review technical reports, regulatory documents, and patents as necessary
  • Champion a 'protocol-driven' and 'report results' methodology
  • Maintain and foster a positive, supportive, and collaborative team culture

Vor Biopharma focuses on developing treatments for blood cancers, particularly Acute Myeloid Leukemia (AML). Their approach is designed to protect healthy cells while specifically targeting and eliminating cancerous cells. This method aims to improve the effectiveness of blood cancer treatments. Vor Biopharma serves patients with blood cancers, their caregivers, and medical professionals in hospitals and oncology centers. What sets Vor Biopharma apart from its competitors is its commitment to extensive research and development of novel therapies, supported by a team with significant experience in the biopharmaceutical field. The company generates revenue through partnerships with other pharmaceutical companies and licensing agreements, with the goal of commercializing their therapies after obtaining regulatory approval.

Company Stage

IPO

Total Funding

$267.8M

Headquarters

Cambridge, Massachusetts

Founded

2015

Growth & Insights
Headcount

6 month growth

-2%

1 year growth

3%

2 year growth

35%
Simplify Jobs

Simplify's Take

What believers are saying

  • Successful transplantation of the first AML patient with Vor Bio’s investigational Trem-cel (VOR33) demonstrates promising clinical progress.
  • The recent $115.8 million funding round strengthens Vor Bio’s financial position, enabling further R&D and potential market expansion.
  • Strategic partnerships, such as the licensing agreement with Editas Medicine, enhance Vor Bio’s capabilities in gene editing and broaden its therapeutic pipeline.

What critics are saying

  • The highly specialized and competitive nature of the biopharmaceutical market requires continuous innovation and significant investment in R&D.
  • Regulatory hurdles and the lengthy approval process for new therapies can delay commercialization and revenue generation.

What makes Vor Bio unique

  • Vor Bio's unique approach of protecting healthy cells while targeting cancerous ones sets it apart in the competitive biopharmaceutical landscape.
  • The company's focus on Acute Myeloid Leukemia (AML) and its proprietary platform for gene-edited hematopoietic stem cell therapies provide a specialized niche.
  • Founded by a Pulitzer Prize-winning author and supported by a team of world-class leaders, Vor Bio leverages exceptional expertise and credibility in the biopharma sector.

Help us improve and share your feedback! Did you find this helpful?